BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17924338)

  • 1. A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy.
    Asimaki A; Syrris P; Wichter T; Matthias P; Saffitz JE; McKenna WJ
    Am J Hum Genet; 2007 Nov; 81(5):964-73. PubMed ID: 17924338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrhythmogenic right ventricular cardiomyopathy mutations alter shear response without changes in cell-cell adhesion.
    Hariharan V; Asimaki A; Michaelson JE; Plovie E; MacRae CA; Saffitz JE; Huang H
    Cardiovasc Res; 2014 Nov; 104(2):280-9. PubMed ID: 25253076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of {beta}-catenin signaling.
    Li J; Swope D; Raess N; Cheng L; Muller EJ; Radice GL
    Mol Cell Biol; 2011 Mar; 31(6):1134-44. PubMed ID: 21245375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease).
    McKoy G; Protonotarios N; Crosby A; Tsatsopoulou A; Anastasakis A; Coonar A; Norman M; Baboonian C; Jeffery S; McKenna WJ
    Lancet; 2000 Jun; 355(9221):2119-24. PubMed ID: 10902626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice.
    Kirchhof P; Fabritz L; Zwiener M; Witt H; Schäfers M; Zellerhoff S; Paul M; Athai T; Hiller KH; Baba HA; Breithardt G; Ruiz P; Wichter T; Levkau B
    Circulation; 2006 Oct; 114(17):1799-806. PubMed ID: 17030684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease).
    Kaplan SR; Gard JJ; Protonotarios N; Tsatsopoulou A; Spiliopoulou C; Anastasakis A; Squarcioni CP; McKenna WJ; Thiene G; Basso C; Brousse N; Fontaine G; Saffitz JE
    Heart Rhythm; 2004 May; 1(1):3-11. PubMed ID: 15851108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy.
    Li D; Liu Y; Maruyama M; Zhu W; Chen H; Zhang W; Reuter S; Lin SF; Haneline LS; Field LJ; Chen PS; Shou W
    Hum Mol Genet; 2011 Dec; 20(23):4582-96. PubMed ID: 21880664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalization of Naxos plakoglobin levels restores cardiac function in mice.
    Zhang Z; Stroud MJ; Zhang J; Fang X; Ouyang K; Kimura K; Mu Y; Dalton ND; Gu Y; Bradford WH; Peterson KL; Cheng H; Zhou X; Chen J
    J Clin Invest; 2015 Apr; 125(4):1708-12. PubMed ID: 25705887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-Exome Sequencing Identified a De Novo Mutation of
    Liu L; Chen C; Li Y; Yu R
    Biomed Res Int; 2019; 2019():9103860. PubMed ID: 31275992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmogenic right ventricular dysplasia, a cell adhesion cardiomyopathy: insights into disease pathogenesis from preliminary genotype--phenotype assessment.
    Tsatsopoulou AA; Protonotarios NI; McKenna WJ
    Heart; 2006 Dec; 92(12):1720-3. PubMed ID: 16698823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of plakoglobin immunoreactivity in intercalated discs in arrhythmogenic right ventricular cardiomyopathy: protein mislocalization versus epitope masking.
    Kant S; Krusche CA; Gaertner A; Milting H; Leube RE
    Cardiovasc Res; 2016 Feb; 109(2):260-71. PubMed ID: 26676851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparate effects of different mutations in plakoglobin on cell mechanical behavior.
    Huang H; Asimaki A; Lo D; McKenna W; Saffitz J
    Cell Motil Cytoskeleton; 2008 Dec; 65(12):964-78. PubMed ID: 18937352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal connexin43 in arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 mutations.
    Fidler LM; Wilson GJ; Liu F; Cui X; Scherer SW; Taylor GP; Hamilton RM
    J Cell Mol Med; 2009 Oct; 13(10):4219-28. PubMed ID: 18662195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of arrhythmogenic right ventricular cardiomyopathy--status quo and future perspectives.
    Paul M; Schulze-Bahr E; Breithardt G; Wichter T
    Z Kardiol; 2003 Feb; 92(2):128-36. PubMed ID: 12596074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMEM43 mutation p.S358L alters intercalated disc protein expression and reduces conduction velocity in arrhythmogenic right ventricular cardiomyopathy.
    Siragam V; Cui X; Masse S; Ackerley C; Aafaqi S; Strandberg L; Tropak M; Fridman MD; Nanthakumar K; Liu J; Sun Y; Su B; Wang C; Liu X; Yan Y; Mendlowitz A; Hamilton RM
    PLoS One; 2014; 9(10):e109128. PubMed ID: 25343256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.
    Garcia-Gras E; Lombardi R; Giocondo MJ; Willerson JT; Schneider MD; Khoury DS; Marian AJ
    J Clin Invest; 2006 Jul; 116(7):2012-21. PubMed ID: 16823493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular changes in the heart of a severe case of arrhythmogenic right ventricular cardiomyopathy caused by a desmoglein-2 null allele.
    Gehmlich K; Syrris P; Reimann M; Asimaki A; Ehler E; Evans A; Quarta G; Pantazis A; Saffitz JE; McKenna WJ
    Cardiovasc Pathol; 2012; 21(4):275-82. PubMed ID: 22036071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiopathogenesis of arrhythmogenic right ventricular cardiomyopathy.
    Dokuparti MVN; Pamuru PR; Thakkar B; Tanjore RR; Nallari P
    J Hum Genet; 2005; 50(8):375-381. PubMed ID: 16096717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships Between Clinical Characteristics and Decreased Plakoglobin and Connexin 43 Expressions in Myocardial Biopsies From Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Yoshida T; Kawano H; Kusumoto S; Fukae S; Koga S; Ikeda S; Koide Y; Abe K; Hayashi T; Maemura K
    Int Heart J; 2015; 56(6):626-31. PubMed ID: 26549284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated JUP plakoglobin gene mutation with left ventricular fibrosis in familial arrhythmogenic right ventricular cardiomyopathy.
    Zinkovsky D; Sood MR
    J Cardiovasc Electrophysiol; 2023 Oct; 34(10):2112-2121. PubMed ID: 37717241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.